Archive: 2026/01

Between 2023 and 2025, hundreds of generic drugs were approved by the FDA but blocked from market by patent lawsuits. This article breaks down how patent litigation delays affordable medications, costs patients billions, and why the system is broken.
Authorized generics are identical to brand-name drugs but sold without the brand label. They offer the same effectiveness as the original, often at a lower price, and are made by the same manufacturer. Learn how they differ from regular generics and why they matter for patients.